Vendors making this claim are either misinformed or deliberately misleading
In a separate trial involving T2D patients, semaglutide treatment decreased the risk of CKD and cardiovascular death by 24%, delaying the progression of kidney dysfunction over four years
Pure Impact EMS uses electromagnetic stimulation to induce supramaximal contractions in the core, glutes and thighs
Clinical data shows all three sites deliver equivalent total drug exposure over the course of a week
In a 2021 randomized clinical trial published in JAMA, participants who stopped semaglutide regained roughly two-thirds of their prior weight loss within a year, while those who continued maintained or lost additional weight
In another study, chronic GLP1-S treatment in rodent models produced sustained weight loss, primarily by shrinking meal size rather than reducing the number of meals